Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Improvement in Psoriasis Symptoms Associated with Combinations of Biologically Active Natural Substances (SFA-002) with Known Safety Profile

NCT05642182 is registered in ClinicalTrials.gov with SFA Therapeutics as lead sponsor.

NCT NCT05642182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05642182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Improvement in Psoriasis Symptoms Associated with Combinations of Biologically Active Natural Substances (SFA-002) with Known Safety Profile
Lead sponsor
SFA Therapeutics
Phase
Phase 1
Overall status
Recruiting
Start date
March 31, 2022
Completion date
July 31, 2025
Enrollment
90 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis